Pharmaceutical Products – Procurement Of First-Line Antituberculosis Drugs For Continuous Therapy Of Patients With Tuberculosis For The Period June 2025 - July 2027. J04am02, Rifampicin, Isoniazid, 150Mg + 75Mg, Film-Coated Tablet,J04am06, Rifampicin, Isoniazid, Pyrazinamide, Ethambutol, 150Mg + 75Mg + 400Mg + 275Mg, Film-Coated Tablet,J04ac01, Isoniazid, 100Mg, Film-Coated Tablet,J04ac01, Isoniazid, 300Mg, Film-Coated Tablet,J04ab02, Rifampicin, 300Mg, Tablet/Capsule,J04ak02, Ethambutol, 400Mg, Film-Coated Tablet,J04ak02, Ethambutol, 100Mg, Film-Coated Tablet,J04ak01, Pyrazinamide, 500Mg, Tablet,J01ga01, Streptomycin Sulphate, 1G, Powder For Solution For Injection,J01gb06, Amikacin, 500Mg/2Ml, Solution For Injection/Solution For Dissolution Or Infusion,J04ad01, Protionamide, 250Mg, Film-Coated Tablet,J04ab01, Cycloserine, 250Mg, Capsule/Tablet,J01ma12, Levofloxacin, 500Mg, Film-Coated Tablet,J01ma14, Moxifloxacin, 400Mg, Film-Coated Tablet,J01fa09, Clarithromycin, 500Mg, Film-Coated Tablet,V07ab, Water For Injection (Solvents And Diluting Agents), 2Ml, Vehicle For Parenteral Use
